Development of biopharmaceutical parenteral dosage forms by John A. Bontempo

By John A. Bontempo

This up to the moment reference delineates-in a scientific fashion-the acceptable, sequential steps for the formula of secure, powerful, good, and marketable liquid parenteral biopharmaceutical products-covering basics and crucial pathways for every part in addition to its function, functionality, and relation to different levels within the product improvement method. Written by way of specialists at the moment concerned about state of the art advances within the pharmaceutical drug undefined, improvement of Biopharmaceutical Parenteral Dosage kinds ·details biopharmaceuticals which are authorized or present process scientific improvement, together with genetically engineered telephone and engineered vectors within the fermentation technique ·describes purification and characterization innovations for rDNA therapeutics, discussing various kinds of unit operations for isolation, purification, and characterization ·considers preformulation and formula requisites, corresponding to physicochemical homes, drug supply, balance reviews courses, deactivation/denaturation routes, choice of appropriate excipients, and regulatory compliance ·elucidates fundamentals of analytical concepts, tools improvement, separation tools utilizing chromatographic and electrophoretic thoughts, and bioactivity tools masking bioassays and immunoassays for quantifying the soundness of organic task ·shows how one can decide upon the precise filter out for maximizing compatibility and minimizing adsorption and inactivation, reading issues from uncomplicated filtration theories to destiny traits ·reviews the choice method for suitable elastomeric closures, reading actual, chemical, toxicological homes, protein adsorption on elastomeric surfaces, suggestions to reduce/eliminate adsorption, and really good bins for biotechnological purposes ·and extra! offered with worthwhile references, tables, and drawings, this sensible advisor is imperative for pharmaceutical, medicinal, and protein chemists; molecular biologists; strategy engineers; purification scientists; biopharmaceutical and pharmaceutical formulators and product builders; quality controls, caliber insurance, and regulatory compliance team of workers; and upper-level undergraduate and graduate scholars in those disciplines.

Show description

Read Online or Download Development of biopharmaceutical parenteral dosage forms PDF

Similar pharmacy books

Combinatorial Peptide and Nonpeptide Libraries: A Handbook

Reference on compound libraries of peptides, for researchers in natural synthesis, biochemistry, biotechnology, pharmacology, drugs, and medical chemistry. vast insurance of man-made methods and applied sciences, mass spectrometry, and screening assays. forty seven participants, 21 U. S.

Development of biopharmaceutical parenteral dosage forms

This up to date reference delineates-in a scientific fashion-the acceptable, sequential steps for the formula of secure, powerful, sturdy, and marketable liquid parenteral biopharmaceutical products-covering basics and crucial pathways for every section in addition to its goal, functionality, and relation to different levels within the product improvement strategy.

Dietary Supplements and Functional Foods

The learn of dietary supplementations has turn into more and more vital inside of orthodox institutions in the course of the international, and because the marketplace for those items maintains to develop, so does the necessity for complete scientifically sound information regarding those items, their houses and strength well-being results.

Steroid-Protein Interactions

This is often the tale of steroid-protein interactions as one investigator sees it. Following the final proposal of this monograph sequence, it emphasizes the consequences and interpretations received within the author's laboratory, and is for that reason a subjective account. spotting, how­ ever, that the dialogue of the topic will be incomplete if the cloth have been restricted to at least one scientist's paintings, the fundamental in attaining­ ments of alternative investigators were included.

Additional resources for Development of biopharmaceutical parenteral dosage forms

Example text

In addition to covalent modifications, rDNA-derived proteins also interact noncovalently with other classes of chemical substances. Many proteins possess metal ion binding sites. Even 316 L stainless steel used ubiquitously for preparation of biopharmaceuticals corrodes slowly, releasing low levels of constituent metal ions. Once bound, proteins may continue to carry these ions despite downstream processing, including extensive diafiltration. Some types of protein bind lipids, such as hepatitis B surface Page 25 antigen and albumin.

In: Creighton TE, ed. Protein Structure, A Practical Approach. Oxford: IRL Press, 1989:311. 8. Timasheff SN, Arakawa T. In: Creighton TE, ed. Protein Structure, A Practical Approach. Oxford: IRL Press, 1989:311. 9. Arakawa T, et al. Pharm Res 1991; 8:225. 10. Schein CH. Biotechnology 1990; 8:308. Page 10 Page 11 2 Fermentation Process Events Affecting Biopharmaceutical Quality ANTHONY S. LUBINIECKI SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania I. INTRODUCTION 12 II. BIOLOGICAL PROCESSES 14 III.

Oxford: IRL Press, 1989:311. 9. Arakawa T, et al. Pharm Res 1991; 8:225. 10. Schein CH. Biotechnology 1990; 8:308. Page 10 Page 11 2 Fermentation Process Events Affecting Biopharmaceutical Quality ANTHONY S. LUBINIECKI SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania I. INTRODUCTION 12 II. BIOLOGICAL PROCESSES 14 III. GENETIC CONSTRUCTION 16 IV. GENE EXPRESSION 19 V. CELL PHYSIOLOGY 20 VI. MEDIUM COMPONENTS 23 VII. BIOLOGICAL CONTAMINANTS 25 VIII. PHARMACOLOGICALLY ACTIVE CONTAMINANTS 27 IX.

Download PDF sample

Rated 4.46 of 5 – based on 16 votes